Suji Jeong, PhD, is the Founding Partner of The SJR Group, a consulting firm that specializes in providing strategic guidance and CFO services tailored to the radiopharmaceuticals industry. Prior to founding The SJR Group, Jeong was a biotechnology equity research analyst at Jefferies, where she was responsible for covering a diverse range of therapeutic sectors and was one of the first analysts on Wall Street to cover radiopharmaceuticals. She began her biotech equity research career at Morgan Stanley and holds a PhD from Northwestern University.